J Rask-Madsen - Concepedia

Author

J Rask-Madsen

Also Known As

J RASKMADSEN, J Rask-Madsen, Jørgen Rask-Madsen, J. RASK-MADSEN, J. RASK‐MADSEN, J. Rask-Madsen, J. Rask-madsen, J. Raskmadsen, J. Rask‐Madsen, J. Rask–Madsen

157

Publications

6.8K

Citations

H-Index

Concepts

All Affiliations

University of Copenhagen Odense University Hospital Herlev Hospital Glostrup Hospital Bispebjerg Hospital

About

J Rask-Madsen is an author at University of Copenhagen specializing in medicine, gastroenterology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	49	3.7K
2	Health Sciences	3	3	166
3	Allergy	3	3	324
4	Engineering	2	2	135
5	Social Sciences	2	2	40

J Rask-Madsen

Publications

5.9K

Citations

H-Index

Page 1

	Year	Citations
Natalizumab for Active Crohn's Disease Subrata Ghosh, Eran Goldin, F. Gordon, New England Journal of Medicine	2003	814
BACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS Michael Tvede, J Rask-Madsen The Lancet Antimicrobial StewardshipAntibioticsTraveler DiarrheaMicrobiologyInfection Control	1989	489
Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis K. Lauritsen, Laurits S. Laursen, Klaus Bukhave, Gastroenterology InflammationAnti-inflammatoryMedicineImmunologyGastroenterology	1986	267
High glucose impairs superoxide production from isolated blood neutrophils Anders Perner, S. E. Nielsen, J Rask-Madsen Intensive Care Medicine InflammationBiochemistryGranulocyteLipid PeroxidationDiabetes	2003	191
Effect of Omeprazole and Cimetidine on Duodenal Ulcer K. Lauritsen, S. J. Rune, Peter Bytzer, New England Journal of Medicine Anti-inflammatory AgentsInvestigational Proton-pump InhibitorGastrointestinal PharmacologyMedicinePostoperative Pain Management	1985	188
In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis K. Lauritsen, Laurits S. Laursen, Klaus Bukhave, Gastroenterology InflammationVivo ProfilesAnti-inflammatoryClostridium Difficile ColitisAllergy	1988	183
Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion. L. Laursen, Morten Gersel Stokholm, Klaus Bukhave, Gut Drug AnalysisFunctional Gastrointestinal DisorderInactive Ulcerative ColitisPharmacologyGastroenterology	1990	168
Involvement of 5-Hydroxytryptamine, Prostaglandin E2, and Cyclic Adenosine Monophosphate in Cholera Toxin-Induced Fluid Secretion in the Small Intestine of the Rat In Vivo Eckhard Beubler, G. Kollár, Alois Saria, Gastroenterology Prostaglandin E2BiochemistrySmall IntestineMedicinePhysiology	1989	154
Colonic Azodisalicylate Metabolism Determined by In Vivo Dialysis in Healthy Volunteers and Patients With Ulcerative Colitis K. Lauritsen, J.P. Hart Hansen, M. Ryde, Gastroenterology BiochemistryMedicinePharmacologyGastroenterologyDigestive Tract	1984	141
Selective 5-lipoxygenase inhibition in ulcerative colitis L. Laursen, K. Lauritsen, J Rask-Madsen, The Lancet InflammationAnti-inflammatoryMedicineGastroenterologyUlcerative Colitis	1990	135

Page 1